Synthesis Procedures
Compound S3. Bis(phthalimidylpropyl)amine (S3) was synthesized following a previously published report. 1 Briefly, phthalic anhydride (S2) (5.0 g, 33.8 mmol) was added to a solution of bis(3-aminopropyl)amine (S1) (2.03 g, 15.5 mmol) in toluene/DMF (50 mL/5 mL). The reaction mixture was stirred under reflux for 24 hours. The solvent was then evaporated and EtOH was (100 mL) added to the residue. The resultant mixture was stirred for 5 hours, the precipitate filtered, and dried to give compound S3 (yield: 75%).
1 H NMR (400 MHz, CDCl 3 ): δ = 7.83 (m, 4H), 7.70 (m, 4H), 3.75 (t, J = 6.8 Hz, 4H), 2.62 (t, J = 6.8 Hz, 4H), 1.84 (quintet, J = 6.8 Hz, 4H).
Compound S5. To a solution of protected lysine S4 (2.0 g, 5.3 mmol) in THF (10 mL), were added the pthalimide protected secondary amine S3 (2.1 g, 5.3 mmol), dicyclohexylcarbodiimide (1.1 g, 5.5 mmol) and triethylamine (0.6 g, 5.5 mmol). The resultant solution was stirred for 24 hours, filtered and the solvent evaporated. The crude product was purified by flash chromatography (ethyl acetate/hexane 1:1) to give lysine derivative S5 (2.3 g, 3.0 mmol, 57%) as a white solid. 
Determining the Gd to Ga ration in Gd 6
LGa by ICP mass Calibration curve was obtained by injecting various known concentrations of gallium and gadolinium salts in the ICP-mass. Various known concentrations of gallium and gadolinium salts were obtained by dissolving their chlorides in a 2.5 % HCl solution. All dilutions were performed in 2.5 % HCl solution. The solutions used for T 1 mapping (a1-c1) were then injected to the ICP-mass to get the concentration of the two salts. Replicates of each concentration were performed.
Samples Gadolinium (mM) Gallium (mM) Ratio Gd:Ga a-1 The α v β 3 integrin-binding affinities of c(RGDyK), Gd 6 H 3 L[c(RGDyK)] 3 and Gd 6 H 3 L[PEG 12 c(RGDyK)] 3 were determined by a competitive cell-binding assay using 125 Iechistatin (PerkinElmer) as the α v β 3 -specific radioligand. The experiments were performed on U87MG human glioblastoma cells following a previously reported method. 2 Briefly, U87MG cells were grown in RPMI 1640 medium supplemented with penicillin, streptomycin, and 10% (v/v) fetal bovine serum (FBS) at 37 °C under 5% CO 2 . Suspended U87MG cells in binding buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 1 mM MnCl 2 , 0.1% bovine serum albumin) were seeded on multiwell DV plates (Millipore) with 5 × 10 4 cells per well and then incubated with 125 I-echistatin (10 000 cpm/well) in the presence of increasing concentrations (0-5000 nM) of c(RGDyK) peptide conjugates for 2 h. The final volume in each well was maintained at 200 μL. At the end of incubation, unbound 125 I-echistatin was removed by filtration followed by three rinses with cold binding buffer. The retentate was collected and the radioactivity was measured using a γ-counter. The best-fit IC 50 values (inhibitory concentration where 50% of the 125 I-echistatin bound on U87MG cells are displaced) of c(RGDyK), Gd 6 H 3 L[c(RGDyK)] 3 and Gd 6 H 3 L[PEG 12 c(RGDyK)] 3 were calculated by fitting the data with nonlinear regression using GraphPad Prism (GraphPadSoftware, Inc.). Experiments were repeated with quintuplicate samples.
